Literature DB >> 22109818

Access to genetic testing and genetic counseling in vulnerable populations: the d/Deaf and hard of hearing population.

Sandra Cooke-Hubley1, Victor Maddalena.   

Abstract

Genetic testing holds great potential for preventing morbidities and mortalities for a number of diseases through early detection and effective intervention. As the number of genetic tests expand, so will public demand for these services. Therefore, it is essential to evaluate access to genetic testing and genetic services to ensure that all Canadians, including vulnerable groups, have equitable access to all forms of health care, in keeping with the mandate of the Canadian Health Act. The purpose of this paper is to examine the literature to determine if and how the Deaf community, as a vulnerable group, is at an increased risk of inequitable access to genetic services in Canada and to discuss how those who are deaf and hard of hearing are subject to the same risks. First, we define vulnerability and describe why the Deaf community, as a social group, can be considered a vulnerable group, followed by a description of the benefits of genetic testing. Second, we describe the barriers to accessing genetic testing, and how the d/Deaf and hard of hearing population experience additional barriers. Third, we examine the difficulties incorporating genetic testing into medical practice, and how this creates additional barriers to those already at risk. Finally, we discuss the steps necessary to promote equitable access to genetic testing among the d/Deaf and hard of hearing populations within Canada, and provide recommendations for further research in this topic area. Lastly, we comment on how barriers to genetic testing vary among the d/Deaf and hard of hearing is dependent upon the type of health care system available (whether public or private).

Year:  2011        PMID: 22109818      PMCID: PMC3186030          DOI: 10.1007/s12687-011-0047-z

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  41 in total

1.  American Sign Language and end-of-life care: research in the deaf community.

Authors:  Barbara Allen; Nancy Meyers; John Sullivan; Melissa Sullivan
Journal:  HEC Forum       Date:  2002-09

Review 2.  The implications of genetic testing for deafness.

Authors:  Kathleen S Arnos
Journal:  Ear Hear       Date:  2003-08       Impact factor: 3.570

3.  Research agenda. Opportunities for research and NIH.

Authors:  Francis S Collins
Journal:  Science       Date:  2010-01-01       Impact factor: 47.728

4.  Prenatal diagnosis for inherited deafness--what is the potential demand?

Authors:  A Middleton; J Hewison; R Mueller
Journal:  J Genet Couns       Date:  2001-04       Impact factor: 2.537

5.  Health care system accessibility. Experiences and perceptions of deaf people.

Authors:  Annie G Steinberg; Steven Barnett; Helen E Meador; Erin A Wiggins; Philip Zazove
Journal:  J Gen Intern Med       Date:  2006-03       Impact factor: 5.128

6.  Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey.

Authors:  Louise Wideroff; Susan Thomas Vadaparampil; Nancy Breen; Robert T Croyle; Andrew N Freedman
Journal:  Community Genet       Date:  2003

7.  Parental perspective of the benefits of genetic testing in children with congenital deafness.

Authors:  E A Geelhoed; K Harrison; A Davey; I R Walpole
Journal:  Public Health Genomics       Date:  2009-02-20       Impact factor: 2.000

8.  Attitudes of deaf adults toward genetic testing for hereditary deafness.

Authors:  A Middleton; J Hewison; R F Mueller
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

9.  A focus group study of consumer attitudes toward genetic testing and newborn screening for deafness.

Authors:  Sarah K Burton; Kara Withrow; Kathleen S Arnos; Andrea L Kalfoglou; Arti Pandya
Journal:  Genet Med       Date:  2006-12       Impact factor: 8.822

10.  Postal survey of physicians and laboratories: practices and perceptions of molecular oncology testing.

Authors:  Fiona A Miller; Paul Krueger; Robert J Christensen; Catherine Ahern; Ronald F Carter; Suzanne Kamel-Reid
Journal:  BMC Health Serv Res       Date:  2009-07-30       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.